Subclonal NT5C2 mutations are associated with poor outcomes after relapse of pediatric acute lymphoblastic leukemia.

导出 OA

翻译打印收藏纠错

第一作者： Malwine J,Barz

第一单位： Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin-Berlin Institute of Health, Berlin, Germany.

作者： Malwine J,Barz ^[1] ; Jana,Hof ^[1] ; Stefanie,Groeneveld-Krentz ^[1] ; Jui Wan,Loh ^[2] ; Annabell,Szymansky ^[3] ; Kathy,Astrahantseff ^[1] ; Arend,von Stackelberg ^[1] ; Hossein,Khiabanian ^[4] ; Adolfo A,Ferrando ^[5] ; Cornelia,Eckert ^[6] ; Renate,Kirschner-Schwabe ^[6]

作者单位： Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin-Berlin Institute of Health, Berlin, Germany. ^[1] Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ.;Graduate Program in Microbiology and Molecular Genetics, Rutgers University, Piscataway, NJ. ^[2] Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin-Berlin Institute of Health, Berlin, Germany.;Institute of Biology, Freie Universität Berlin, Berlin, Germany. ^[3] Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ.;Graduate Program in Microbiology and Molecular Genetics, Rutgers University, Piscataway, NJ.;Department of Pathology and Laboratory Medicine, Rutgers Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ. ^[4] Institute of Cancer Genetics, Columbia University, New York, NY; and. ^[5] Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin-Berlin Institute of Health, Berlin, Germany.;German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany. ^[6]